Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
Researchers conducted a systematic review to assess the risk of bias and applicability of prediction models for fear of recurrence in patients with cancer.
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma Predicting severe adverse events (SAEs) in oncology is ...
Kumo Launches KumoRFM-2, A Foundation Model Built to Replace Traditional Enterprise Machine Learning
Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...
Mount Sinai researchers have created an analytic tool using machine learning that can predict cardiovascular disease risk in patients with obstructive sleep apnea ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
Two complementary predictors (DAAE-M and ELIE) estimate individualized 5-year progression risk using routine clinical data, ...
In my latest Signal Spot, I had my Villanova students explore machine learning techniques to see if we could accurately ...
Using Python, web scraping, and advanced algorithms, the solution aggregates real-time data from marketplaces to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results